Biogen is leaning on newer drugs, including recently acquired assets, as its multiple sclerosis franchise faces ongoing ...
Brian Sozzi's case against the retirement narrative is grounded in what Dimon is actually doing: JPMorgan helped bring SpaceX's IPO to everyday investors, and Sozzi expects Dimon to run the same play ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results